Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    2,634

Stocks News & Analysis

stocks

The World Cup stock you’ve never heard of

This ASX stock is kicking goals at the FIFA World Cup.
stocks

Chart of the Week: Can WiseTech shares finally bounce back?

Market concerns over governance and AI fears have left shares trading well below the fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,003.7034.900.39%
CAC 408,326.6273.960.90%
DAX 4025,118.27220.820.89%
Dow JONES (US)52,487.41139.020.27%
FTSE 10010,472.4516.59-0.16%
HKSE24,470.23440.051.83%
NASDAQ26,206.89336.241.30%
Nikkei 22568,964.051,220.201.80%
NZX 50 Index13,785.67120.490.88%
S&P 5007,543.6460.930.81%
S&P/ASX 2008,806.4038.600.44%
SSE Composite Index4,067.0730.480.76%

Market Movers